Search

everythinglearnresearchcommunity

for

Search:↓

Almost all kidney transplant patients had complications from immunosuppressive therapy, with excessive hair growth being the most common.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Targeting the AhR pathway may help treat alopecia areata.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

AS101 reduces hair loss from chemotherapy.

Calancardin B may help reduce inflammation in immune cells.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

The role of γδT-cells in causing alopecia areata remains unclear.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Alopecia areata involves unique activation of certain immune cells.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

Immune cells are crucial for normal skin development and their dysfunction can cause skin disorders.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Cancer treatments often cause skin, nail, and hair problems.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Certain substances can help skin cells become anti-inflammatory, aiding in tissue repair.